ICFI · XBRL financial data
ICF International financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (ICFI's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 502 | 478* | 494 | 512 | 517 | 496* | 488 | 476 | 465 | 444* | 438 | 474 |
| Cost of goods and services sold | 324 | 304* | 311 | 329 | 325 | 317* | 303 | 298 | 291 | 285* | 271 | 298 |
| Selling, general and administrative | 132 | 123* | 129 | 127 | 133 | 129* | 132 | 123 | 122 | 115* | 119 | 123 |
| Total operating expenses | 146 | 138* | 143 | 140 | 146 | 143* | 147 | 138 | 136 | 130* | 132 | 137 |
| Operating income (loss) | 32 | 37* | 41 | 42 | 46 | 36* | 38 | 40 | 38 | 29* | 35 | 40 |
| Interest expense | — | year only | 8 | 8 | 7 | 7* | 7 | 8 | 8 | 7* | 7 | 7 |
| Other income (expense) | 3 | 2* | 2 | 0 | (1) | 1* | (1) | (2) | 0 | (0)* | (1) | (0) |
| Income tax expense (benefit) | 0 | 8* | 7 | 9 | 5 | 6* | 3 | 6 | 7 | 4* | 7 | 6 |
| Net income (loss) | 24 | 22* | 27 | 26 | 33 | 25* | 27 | 24 | 24 | 17* | 21 | 27 |
| Earnings per share, basic USD per share | 1.26 | 1.18* | 1.46 | 1.37 | 1.74 | 1.31* | 1.45 | 1.29 | 1.29 | 0.95* | 1.12 | 1.50 |
| Earnings per share, diluted USD per share | 1.25 | 1.16* | 1.44 | 1.36 | 1.73 | 1.29* | 1.44 | 1.28 | 1.28 | 0.94* | 1.12 | 1.49 |
| Weighted average shares, basic millions of shares | 19 | 19* | 19 | 19 | 19 | 19* | 19 | 18 | 18 | 18* | 18 | 18 |
| Weighted average shares, diluted millions of shares | 19 | 19* | 19 | 19 | 19 | 19* | 19 | 18 | 19 | 18* | 18 | 18 |
Balance sheet
CSVFiscal quarters (ICFI's year ends in late December)
Cash flows
CSVFiscal quarters (ICFI's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 24 | 22* | 27 | 26 | 33 | 25* | 27 | 24 | 24 | 17* | 21 | 27 |
| Stock-based compensation | 3* | 5* | 4 | 5* | 4* | 4* | 4 | 4* | 4* | 5* | 5 | 4* |
| Depreciation and amortization | 15* | 15* | 14 | 13* | 13* | 13* | 15 | 15* | 14* | 14* | 13 | 13* |
| Net cash from operating activities | 26* | 107* | (10) | 61* | 26* | 95* | (33) | 52* | 47* | 76* | (3) | 100* |
| Net cash from investing activities | 42* | (0)* | (4) | (5)* | (5)* | (61)* | (3) | (5)* | (6)* | (7)* | (3) | (6)* |
| Dividends paid | 3* | 3* | 3 | 3* | 3* | 3* | 3 | 3* | 3* | 3* | 3 | 3* |
| Repayments of long-term debt | 371* | 377* | 312 | 346* | 273* | 318* | 422 | 283* | 306* | 348* | 270 | — |
| Net cash from financing activities | (71)* | (106)* | 9 | (55)* | (18)* | (22)* | 41 | (45)* | (15)* | (66)* | 15 | (50)* |
| Net change in cash | (4)* | 2* | (5) | 0* | 3* | 11* | 5 | 3* | 27* | 2* | 9 | 44* |
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| Premier | 43 | 240 | 16 | 82.7M | — | 10-QSep 30, 2025 |
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
| Huron Consulting Group | 26 | 491 | 57* | 15.8M | — | 10-QSep 30, 2026 |
| Exponent | 67 | 172 | 31* | 47.5M | — | 10-QJul 3, 2026 |
| Onterris | 13 | 187 | 6.2* | 35.1M | — | 10-QJun 30, 2026 |
| V2X | 265 | 1,271 | 67* | 31.4M | — | 10-QOct 2, 2026 |
| TSS | 68 | 35 | 7.6* | 28.2M | — | 10-Q/AJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.